Are Brigatinib and Brigatinib the same medicine?

Brigatinib/Brigatinib and brigatinib are the same drug. It is a tyrosine kinase inhibitor that can inhibit a variety of enzymes that play an important role in the occurrence and development of tumors, including ALK. Brigatinib is another brand name of brigatinib. They are different names for the same drug. Common names include ALUNBRIG, which is the trade name under which this drug is sold.

Brigatinib is an oral, potent and selective anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) tyrosine kinase inhibitor, indicated for the treatment of adults with non-small cell Prescription drugs for lung cancer (NSCLC) , cancer tumors tested in these patients may include having a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, and the tumor has spread to other parts of the body. It is unclear whether brigatinib is safe and effective in children. In a multinational Phase III study (ALTA-1L) in this patient population, brigatinib significantly improved median blinded independent review committee-assessed progression-free survival (PFS), confirmed objective response (OR) rate, and confirmed intracranial OR rate compared with crizotinib.

This original drug is marketed in China under the name brigatinib, and has entered the scope of Class B medical insurance. Specifications The price of 30mg*14 tablets*2 tablets per box may be around 8,000 yuan, which is relatively expensive. Currently, there are relatively cheap generic brigatinib drugs on the market overseas. Their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of a box of 90mg*30 tablets produced by a Bangladesh pharmaceutical factory is around 2,000 yuan (the price may fluctuate due to exchange rates).